BioWorld - Monday, February 16, 2026

bispecifics

28 items

european union

28 items

hidradenitis suppurativa

28 items

mrna-1273

28 items

targeted protein degradation

28 items

senescence

28 items

cardiomyopathy

28 items

inflammatory diseases

28 items

liver fibrosis

28 items

mounjaro

28 items

layoffs

28 items

federal circuit

28 items

tead inhibitors

28 items

hemophilia b

28 items

guardant health inc.

28 items

hypertrophic cardiomyopathy

28 items

mita

28 items

biotechnology innovation organization

28 items

anti-pd-1

28 items

abiomed inc.

28 items